A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Clinical trial NCT04421378 · TERMINATED
Trial details
- NCT number
- NCT04421378
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-08
- Primary completion
- 2023-07-03
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.